Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Gizmodo may earn an affiliate commission. Reading time 3 minutes Of ...

TL;DR: Microsoft ended security updates for Windows 10 in October, leaving around 1 billion PCs at increased risk. While 500 million devices can upgrade to Windows 11, many delay due to strict ...

The era of Windows 10 is officially over, and Windows 11 has taken over. Microsoft ended support for their former OS in October, although it will still offer security updates for one more year. Plenty ...

Officially, Windows 10 died last month, a little over a decade after its initial release. But the old operating system’s enduring popularity has prompted Microsoft to promise between one and three ...

Microsoft admitted that a bug is wrongly telling some Windows 10 users that they’re “out of support.” This is confusing because support hasn’t fully ended for everyone. You can still extend Windows 10 ...